These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22823969)

  • 1. Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.
    Xu X; Yang W; Li Y; Wang Y
    Expert Opin Drug Discov; 2010 Jan; 5(1):21-31. PubMed ID: 22823969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore-based virtual screening: a review of recent applications.
    Kim KH; Kim ND; Seong BL
    Expert Opin Drug Discov; 2010 Mar; 5(3):205-22. PubMed ID: 22823018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
    Franco R; Canela EI; Casado V; Ferre S
    Expert Opin Drug Discov; 2010 Apr; 5(4):391-403. PubMed ID: 22823089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of chemical libraries for screening.
    Villar HO; Hansen MR
    Expert Opin Drug Discov; 2009 Dec; 4(12):1215-20. PubMed ID: 23480462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors.
    Eglen RM; Reisine T
    Expert Opin Drug Discov; 2010 Mar; 5(3):277-90. PubMed ID: 22823023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When analoging is not enough: scaffold discovery in medicinal chemistry.
    Zhao H; Akritopoulou-Zanze I
    Expert Opin Drug Discov; 2010 Feb; 5(2):123-34. PubMed ID: 22822912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current strategies for drug discovery through natural products.
    Harvey AL; Clark RL; Mackay SP; Johnston BF
    Expert Opin Drug Discov; 2010 Jun; 5(6):559-68. PubMed ID: 22823167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors.
    Deng H
    Expert Opin Drug Discov; 2010 Oct; 5(10):961-93. PubMed ID: 22823990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening of the estrogen receptor.
    Knox AJ; Yang Y; Lloyd DG; Meegan MJ
    Expert Opin Drug Discov; 2008 Aug; 3(8):853-66. PubMed ID: 23484963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore models for GABA(A) modulators: implications in CNS drug discovery.
    Ghoshal N; Vijayan RS
    Expert Opin Drug Discov; 2010 May; 5(5):441-60. PubMed ID: 22823129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in LC platforms for drug discovery.
    Nicoli R; Martel S; Rudaz S; Wolfender JL; Veuthey JL; Carrupt PA; Guillarme D
    Expert Opin Drug Discov; 2010 May; 5(5):475-89. PubMed ID: 22823131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for computational screening of non-steroidal androgen receptor ligands.
    Nyrönen TH; Söderholm AA
    Expert Opin Drug Discov; 2010 Jan; 5(1):5-20. PubMed ID: 22823968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico fragment-based drug design.
    Konteatis ZD
    Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biasing conformational ensembles towards bioactive-like conformers for ligand-based drug design.
    Musafia B; Senderowitz H
    Expert Opin Drug Discov; 2010 Oct; 5(10):943-59. PubMed ID: 22823989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2013 Apr; 8(4):411-26. PubMed ID: 23373617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-mammalian animal models of Parkinson's disease for drug discovery.
    Lim KL
    Expert Opin Drug Discov; 2010 Feb; 5(2):165-76. PubMed ID: 22822916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What does systems biology mean for biomarker discovery?
    Azuaje F
    Expert Opin Med Diagn; 2010 Jan; 4(1):1-10. PubMed ID: 23496106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.